Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Tezepelumab Regulatory Submission Accepted and Granted FDA Priority Review in the US for the Treatment of Patients with Asthma
AstraZeneca’s Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for […]
Exscientia Accelerates COVID-19 Drug Discovery Using AI
Exscientia has received a grant from the Bill & Melinda Gates Foundation and Gates Philanthropy […]
Researchers Behind Lifesaving Astra-Zeneca Jab Named Winners Of NHS Gong
Research teams at Oxford University who joined forces to fight coronavirus by developing a covid […]
Better Contracted to Deliver Clinical Data Repository for Wales
Digital Health and Care Wales has awarded a two-year contract to Better for a clinical […]
Robocath and Rennes University Hospital Launch Co-development Research Program into Treatment of Strokes in Partnership with Philips France
Robocath, a company that designs, develops and commercializes robotic solutions to treat cardiovascular diseases, and […]
Univercells Technologies and VectorBuilder Announce Strategic Partnership for Optimized Custom Viral Vector Production
Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production, has […]
Otsuka Signs Three-Year Collaboration with Holmusk to Enhance Digital Health and Data Analytics for Global Behavioral Health Programs
Otsuka Pharmaceutical Development & Commercialization, Inc. (“Otsuka”), announces today that it has entered a three-year […]
Genoskin Launches ISR Platform®, the First Human Skin Ex Vivo Platform to Study Injection Site Reactions (ISR)
Genoskin, a biotechnology company that provides transformative platforms and tools leveraging human skin to test […]
First Naturally-designed and Personalised Bioprosthesis SingValve Set to Revolutionise Heart Valve Surgery
A naturally-designed human-like personalised heart valve bioprosthesis named SingValve developed by a team of clinician-scientists […]
Sosei Heptares and InveniAI Enter a Multi-target AI-powered and GPCR-focused Drug Discovery Collaboration
Sosei Group Corporation (“the Company”) (TSE: 4565), the world leader in GPCR-focused structure-based drug design and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more